Literature DB >> 1342100

Immune response in mice immunized with acidic antigenic fractions from Trypanosoma cruzi cytosol.

S Gea1, A Gruppi, F Cerban, M C Pistoresi Palencia, E Vottero-Cima.   

Abstract

The humoral and cellular immune responses as well as the resistance to infection with bloodstream forms of T. cruzi were studied in mice immunized with acidic antigenic fractions from parasite cytosol, F III and F IV, plus Bordetella pertussis as adjuvant. The immunization with F III induced positive ITH and DTH responses to homologous antigens. In mice immunized with F IV, the ITH was negative and four out of six animals presented positive DTH reactions. In both groups of mice the analysis of IgG against T. cruzi showed that the major isotype elicited was IgG1. Specific IgE was also detected in sera from F III immunized mice, thus confirming the presence of homocytotropic antibodies. The parasitemias reached by F III and F IV immunized mice after challenge were lower than those of the controls showing in this way a partial protection against the acute infection. The histological studies of heart and skeletal muscle performed two months after the infection revealed variable mononuclear infiltration in all infected mice despite immunization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342100     DOI: 10.1590/s0036-46651992000500003

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  2 in total

1.  Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi.

Authors:  Paola Gobbi; Alejandra Baez; Maria Silvina Lo Presti; Alicia R Fernández; Julio E Enders; Ricardo Fretes; Susana Gea; Patricia A Paglini-Oliva; Hector Walter Rivarola
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

2.  3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.

Authors:  Carolina P Knubel; Fernando F Martínez; Eva V Acosta Rodríguez; Andrés Altamirano; Héctor W Rivarola; Cintia Diaz Luján; Ricardo E Fretes; Laura Cervi; Claudia C Motrán
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.